Irena Kejhova

Title: Irena Kejhova: Innovator in Antitumor Drug Development

Introduction

Irena Kejhova is a prominent inventor based in Praha, Czech Republic. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor compounds. With a total of 2 patents, her work focuses on innovative drug formulations that target malignant neoplasias.

Latest Patents

Irena's latest patents include the development of 6-[X-(2-hydroxyethyl)aminoalkyl]-5,11-dioxo-5,6-dihydro-11H-indeno[-1,2-c]isochinoline derivatives. These compounds are characterized by a general formula where X represents the number of carbon atoms from 0 to 5 in the aminoalkyl group. The preparation of these antitumor compounds involves reacting indeno[1,2-c]isocoumarine with N-(hydroxyethyl)alkylen diamine in a suitable aprotic solvent, such as dimethylformamide, at elevated temperatures. Another method includes the reaction of 6-(X-chloroalkyl)-5,11-dioxo-5,6-dihydro-11H-indeno[1,2-c]isochinolines with 2-aminoethanol. These innovative compounds have shown remarkable antineoplastic effects, indicating their potential for treating malignant neoplastic diseases in mammals.

Career Highlights

Throughout her career, Irena has worked with several notable companies, including Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, and Vufb A.s. Her experience in these organizations has contributed to her expertise in drug development and medicinal chemistry.

Collaborations

Irena has collaborated with esteemed colleagues such as Jiri Krepelka and Milan Miko. These partnerships have further enhanced her research and development efforts in the field of antitumor drugs.

Conclusion

Irena Kejhova's innovative work in the development of antitumor compounds showcases her significant contributions to medicinal chemistry. Her patents reflect a commitment to advancing treatments for malignant neoplasias, highlighting her role as a key inventor in this vital area of research.